Cadence Capital Management LLC lifted its stake in shares of U.S. Physical Therapy, Inc. (NYSE:USPH) by 20.1% during the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 12,290 shares of the company’s stock after acquiring an additional 2,053 shares during the quarter. Cadence Capital Management LLC owned 0.10% of U.S. Physical Therapy worth $1,458,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently bought and sold shares of USPH. Acadian Asset Management LLC purchased a new position in U.S. Physical Therapy in the second quarter valued at $106,000. Harvest Fund Management Co. Ltd purchased a new position in U.S. Physical Therapy in the third quarter valued at $190,000. Cambridge Investment Research Advisors Inc. purchased a new position in U.S. Physical Therapy in the second quarter valued at $219,000. Itau Unibanco Holding S.A. purchased a new position in U.S. Physical Therapy in the second quarter valued at $235,000. Finally, PNC Financial Services Group Inc. increased its holdings in U.S. Physical Therapy by 62.7% in the second quarter. PNC Financial Services Group Inc. now owns 2,676 shares of the company’s stock valued at $256,000 after buying an additional 1,031 shares during the last quarter. 97.64% of the stock is currently owned by institutional investors and hedge funds.

In other news, CEO Christopher J. Reading sold 8,768 shares of the stock in a transaction dated Tuesday, August 14th. The shares were sold at an average price of $115.57, for a total transaction of $1,013,317.76. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Clayton Trier sold 1,250 shares of the stock in a transaction dated Friday, August 17th. The stock was sold at an average price of $115.50, for a total transaction of $144,375.00. The disclosure for this sale can be found here. Insiders sold 22,618 shares of company stock valued at $2,617,792 in the last 90 days. 2.50% of the stock is currently owned by insiders.

USPH has been the topic of several recent analyst reports. Barrington Research reissued a “hold” rating on shares of U.S. Physical Therapy in a report on Friday, August 3rd. TheStreet lowered U.S. Physical Therapy from a “b” rating to a “c+” rating in a report on Friday, November 2nd. Zacks Investment Research raised U.S. Physical Therapy from a “hold” rating to a “buy” rating and set a $129.00 target price on the stock in a report on Tuesday, August 7th. Jefferies Financial Group restated a “hold” rating and issued a $105.00 price objective on shares of U.S. Physical Therapy in a research note on Friday, August 3rd. Finally, Cantor Fitzgerald upped their price objective on shares of U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a research note on Friday, November 2nd. Four investment analysts have rated the stock with a hold rating, one has assigned a buy rating and one has issued a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $113.67.

NYSE USPH opened at $115.77 on Friday. The company has a debt-to-equity ratio of 0.26, a current ratio of 1.93 and a quick ratio of 2.06. U.S. Physical Therapy, Inc. has a 1 year low of $67.15 and a 1 year high of $129.65. The firm has a market capitalization of $1.48 billion, a price-to-earnings ratio of 55.66, a P/E/G ratio of 4.05 and a beta of 1.19.

U.S. Physical Therapy (NYSE:USPH) last released its quarterly earnings data on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.06. U.S. Physical Therapy had a net margin of 5.58% and a return on equity of 17.64%. The company had revenue of $113.10 million during the quarter, compared to the consensus estimate of $112.79 million. The business’s quarterly revenue was up 9.8% compared to the same quarter last year. On average, sell-side analysts anticipate that U.S. Physical Therapy, Inc. will post 2.56 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Shareholders of record on Friday, November 9th will be paid a $0.23 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $0.92 annualized dividend and a yield of 0.79%. U.S. Physical Therapy’s dividend payout ratio is presently 44.23%.

TRADEMARK VIOLATION WARNING: This report was originally reported by TheOlympiaReport and is owned by of TheOlympiaReport. If you are accessing this report on another website, it was copied illegally and republished in violation of United States & international trademark & copyright legislation. The original version of this report can be viewed at https://theolympiareport.com/2018/11/11/cadence-capital-management-llc-buys-2053-shares-of-u-s-physical-therapy-inc-usph.html.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Story: What is a Market Correction?

Institutional Ownership by Quarter for U.S. Physical Therapy (NYSE:USPH)

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.